R.MacarthurL
Meanwhile, increased ECM stiffness sustains mechanotransduction signaling in fibroblasts, reinforcing the cycle of immune activation, ECM remodeling, and fibrosis in hypothyroidism-associated MAFLD (143)
The trial also met all key secondary endpoints, including improvements in waist circumference , systolic blood pressure, triglycerides, non-HDL cholesterol, LDL cholesterol, and serum uric acid
70% of the programs in clinical development were antiamyloid programs and anti-tau programs and 20%, 30% were alternate pathways
Most patients tolerate semaglutide well once at maintenance dose, with satisfaction and energy improvements offsetting early adjustment symptoms